Exhibit 99.1

 

 21ST CENTURY ONCOLOGY HOLDINGS, INC.

 CONDENSED CONSOLIDATED BALANCE SHEETS

 (in thousands, except share amounts)

 (unaudited)

 

 

 

PRELIMINARY

 

ADJUSTMENTS

 

 

 

FINAL

 

 

 

 

September 30,

 

September 30,

 

 

 

September 30,

 

 

 

 

2015

 

2015

 

 

 

2015

 

 

 

 

 

 

 

 

 

 

 

 

ASSETS

 

Current assets:

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

47,793

 

$

 

 

 

$

47,793

 

 

Restricted cash

 

80

 

 

 

 

80

 

 

Marketable securities

 

622

 

 

 

 

622

 

 

Accounts receivable, net

 

149,224

 

 

 

 

149,224

 

 

Prepaid expenses

 

9,381

 

 

 

 

9,381

 

 

Inventories

 

5,162

 

 

 

 

5,162

 

 

Deferred income taxes

 

191

 

 

 

 

191

 

 

Other

 

8,056

 

 

 

 

8,056

 

 

Total current assets

 

220,509

 

 

 

 

220,509

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity investments in joint ventures

 

1,236

 

 

 

 

1,236

 

 

Property and equipment, net

 

249,392

 

 

 

 

249,392

 

 

Real estate subject to finance obligation

 

11,625

 

 

 

 

11,625

 

 

Goodwill

 

492,084

 

 

 

 

492,084

 

 

Intangible assets, net

 

74,434

 

 

 

 

74,434

 

 

Other assets

 

49,282

 

 

 

 

49,282

 

 

Total assets

 

$

1,098,562

 

$

 

 

 

$

1,098,562

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

59,397

 

$

 

 

 

$

59,397

 

 

Accrued expenses

 

111,084

 

28,977

 

A

 

140,061

 

 

Income taxes payable

 

1,814

 

 

 

 

1,814

 

 

Current portion of long-term debt

 

30,858

 

 

 

 

30,858

 

 

Current portion of finance obligation

 

481

 

 

 

 

481

 

 

Other current liabilities

 

6,484

 

 

 

 

6,484

 

 

Total current liabilities

 

210,118

 

28,977

 

 

 

239,095

 

 

Long-term debt, less current portion

 

1,009,196

 

 

 

 

1,009,196

 

 

Finance obligation, less current portion

 

12,057

 

 

 

 

12,057

 

 

Embedded derivative & other financial instrument features of Series A convertible redeemable preferred stock

 

23,541

 

3,798

 

B

 

27,339

 

 

Other long-term liabilities

 

39,861

 

 

 

 

39,861

 

 

Deferred income taxes

 

3,716

 

 

 

 

3,716

 

 

Total liabilities

 

1,298,489

 

32,775

 

 

 

1,331,264

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A convertible redeemable preferred stock, $0.001 par value, $1,000 stated value, 3,500,000 authorized, 385,000 issued and outstanding at September 30, 2015 and December 31, 2014

 

404,179

 

(33,701

)

C

 

370,478

 

 

Noncontrolling interests - redeemable

 

19,934

 

 

 

 

19,934

 

 

 

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity:

 

 

 

 

 

 

 

 

 

 

Common stock, $0.01 par value, 1,000,000 shares authorized 1,059 and 1,028 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively

 

 

 

 

 

 

 

Additional paid-in capital

 

569,036

 

30,697

 

D

 

599,733

 

 

Retained deficit

 

(1,174,400

)

(29,771

)

E

 

(1,204,171

)

 

Accumulated other comprehensive loss, net of tax

 

(45,008

)

 

 

 

(45,008

)

 

Total 21st Century Oncology Holdings, Inc. shareholder’s deficit

 

(650,372

)

926

 

 

 

(649,446

)

 

Noncontrolling interests - nonredeemable

 

26,332

 

 

 

 

26,332

 

 

Total deficit

 

(624,040

)

926

 

 

 

(623,114

)

 

Total liabilities and equity

 

$

1,098,562

 

$

 

 

 

$

1,098,562

 

 


The following information was filed by 21St Century Oncology Holdings, Inc. (RTSX) on Friday, February 12, 2016 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate 21St Century Oncology Holdings, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by 21St Century Oncology Holdings, Inc..

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account